HEIFX
Price
$15.96
Change
+$0.01 (+0.06%)
Updated
Nov 13 closing price
RLBEX
Price
$36.56
Change
-$0.05 (-0.14%)
Updated
Nov 13 closing price
Ad is loading...

HEIFX vs RLBEX

Header iconHEIFX vs RLBEX Comparison
Open Charts HEIFX vs RLBEXBanner chart's image
Hennessy Equity and Income Investor
Price$15.96
Change+$0.01 (+0.06%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R4
Price$36.56
Change-$0.05 (-0.14%)
VolumeN/A
CapitalizationN/A
HEIFX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HEIFX vs. RLBEX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HEIFX is a Buy and RLBEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 240B vs. HEIFX (60.7M). RLBEX pays higher dividends than HEIFX: RLBEX (2.24) vs HEIFX (0.57). HEIFX was incepted earlier than RLBEX: HEIFX (23 years) vs RLBEX (22 years). RLBEX is a more actively managed with annual turnover of: 171.00 vs. HEIFX (11.00). RLBEX has a lower initial minimum investment than HEIFX: RLBEX (250) vs HEIFX (2500). RLBEX annual gain was more profitable for investors over the last year : 24.74 vs. HEIFX (10.64). RLBEX return over 5 years is better than : 38.53 vs. HEIFX (3.01).
HEIFXRLBEXHEIFX / RLBEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years22 years-
Gain YTD13.30215.73585%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets60.7M240B0%
Annual Yield % from dividends0.572.2425%
Returns for 1 year10.6424.7443%
Returns for 3 years-7.6512.07-63%
Returns for 5 years3.0138.538%
Returns for 10 years0.1155.310%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCS13.22-0.26
-1.93%
Barclays PLC
IPAR126.00-2.80
-2.17%
Interparfums Inc
KALA7.14-0.27
-3.58%
Kala BIO
KW11.10-0.60
-5.13%
Kennedy-Wilson Holdings
ALDX4.76-0.73
-13.30%
Aldeyra Therapeutics